Article > GSK and XenoPort end pact on restless legs drug – PharmaTimes

by admin on November 28, 2012

Article > GSK and XenoPort end pact on restless legs drug
PharmaTimes
Kevin Grogan. GSK and XenoPort end pact on restless legs drug. GlaxoSmithKline and XenoPort have settled their dispute over Horizant in a move that will see the UK major return the rights to the restless legs syndrome drug. The companies have
GlaxoSmithKline gives up on XenoPort Horizant collaborationThe Pharma Letter

all 4 news articles »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: